Cytokine-induced killer (CIK) cells are a heterogeneous population of highly cytotoxic immune effector cells. Creative Biolabs has developed a series of assays to precisely evaluate apoptotic processes in CIK cells, utilizing cutting-edge technology and a deep understanding of cellular biology.
Fig.1 CIK immunotherapy.1
CIK cell therapy represents a promising approach in cancer treatment, leveraging the potent cytotoxic capabilities of CIK cells against tumor cells. The apoptotic pathways within CIK cells are crucial for regulating their life cycle and function, making apoptosis analysis an essential component of CIK cell studies. The efficacy of CIK therapy can be influenced by the phenomenon of CIK cell apoptosis, particularly through mechanisms involving activation-induced cell death (AICD). A study indicates redirection of CIK cells to tumor targets by CD3 leads to an increase in both CIK cell proliferation and apoptosis.
CIK cells are a heterogeneous population of highly cytotoxic immune effector cells, making them an ideal model for apoptosis studies. Creative Biolabs has developed a series of assays to precisely evaluate apoptotic processes in CIK cells, utilizing cutting-edge technology and a deep understanding of cellular biology. We utilize advanced techniques such as flow cytometry to analyze markers of apoptosis, including Annexin V binding, caspase activation, and DNA fragmentation. These markers provide a comprehensive view of apoptotic events in CIK cells. Our service is suited to distinct phases of apoptosis.
We use fluorescence-labeled annexin V and propidium iodide (PI) staining to distinguish early apoptosis, late apoptosis, and necrosis. This quantitative method offers high sensitivity and specificity.
The terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay is employed to detect DNA fragmentation, a hallmark of apoptosis.
Measurement of caspase enzymes, such as caspase-3 and caspase-7, provides insights into the intrinsic and extrinsic apoptotic pathways in CIK cells.
At Creative Biolabs, our team of experts combines years of experience with state-of-the-art technologies to provide comprehensive apoptosis analysis solutions. By partnering with us, researchers can gain actionable insights into the apoptotic mechanisms affecting CIK cells, empowering the development of innovative cancer therapies. Contact us today to discover how our CIK Apoptosis Analysis Service can support and enhance your research endeavors.
Reference
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
NEWSLETTER
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTER
NEW SOLUTION
CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTION
NOVEL TECHNOLOGY
Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGY
NEW SOLUTION
Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION